Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07314697 · ClinicalTrials.gov registry record · NA
Arrival Time Implementation
A NA study of Primary Care, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 300,000
- Enrollment target
- 1
- Study location
NCT07314697: Recruiting NA study of Primary Care, sponsored by University of California, Los Angeles.
NCT07314697 is a NA study of Primary Care that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 300,000 participants, above the 408-participant average among 5 other Primary Care trials with a reported enrollment target (73429% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07314697, a NA study of Primary Care, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 300,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective clinical trial evaluating how behaviorally informed message framing can improve patient on-time arrival for outpatient visits. This trial is being implemented in conjunction with UCLA Health's broader operational quality improvement (QI) efforts to enhance clinic flow and patient experience. The main question it aims to answer is how displaying an explicit arrival time (set to 15 minutes before the scheduled appointment) affects when patients arrive for their appointments, compared to a control condition where only the appointment time is displayed and patients are encouraged to arrive 15 min before the appointment (without an explicit arrival time).
Primary Outcome
The number of minutes between the patient's check-in time and the scheduled appointment time. A positive (negative) value indicates that the patient arrived before (after) the scheduled appointment time.Winsorization at the 0.5th and 99.5th percentiles will be applied.
Conditions Studied
Interventions
- BEHAVIORAL Behaviorally informed appointment communications
- BEHAVIORAL Control appointment communications
Study Locations (1)
California
- UCLA Health Department of Medicine, Quality Office - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300,000 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT07314697 shows while recruiting
NCT07314697 is an interventional study that assigns participants to a tested intervention. Its 300,000 participants enrollment target places it among the larger protocols in the corpus, above the 408-participant average among 5 other Primary Care trials with a reported enrollment target (73429% higher).
The record links to 1 condition, with Primary Care appearing as the primary indexed condition, and to 2 interventions - of which Behaviorally informed appointment communications is the first listed.
NCT07314697 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07314697 about?
NCT07314697 is a clinical study titled "Arrival Time Implementation". This is a prospective clinical trial evaluating how behaviorally informed message framing can improve patient on-time arrival for outpatient visits. This trial is being implemented in conjunction with UCLA Health's broader operational quality improvement (QI) efforts to enhance clinic flow and patie...
What is the current status of trial NCT07314697?
This trial is currently recruiting. It is a NA study. The enrollment target is 300,000 participants. The study started on 2026-01-05. Estimated completion is 2026-07.
What conditions does trial NCT07314697 study?
This clinical trial studies the following conditions: Primary Care.
What interventions are being tested in trial NCT07314697?
The interventions under investigation include: Behaviorally informed appointment communications (BEHAVIORAL), Control appointment communications (BEHAVIORAL).
Who is sponsoring clinical trial NCT07314697?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07314697 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
RECRUITING · NA
-
Project CARE: CAncer Risk Evaluation
RECRUITING · NA
-
Pilot Trial of Clinic-based Dating Violence Prevention Program for Adolescents and Caregivers
RECRUITING · NA
-
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
ACTIVE NOT RECRUITING · NA
-
Parent Training in Pediatric Care: A Self Directed Tablet-Based Approach
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI